Medicines Australia leads the research-based medicines industry of Australia. Our members discover, develop and manufacture prescription medicine products, biotherapeutic products and vaccines that bring health, social and economic benefits to Australia. Our members are committed to the highest ethical standards as they invest in Australian medical research and take local discoveries and developments to the world.
Chief Executive Officer
Lorraine leads AusBiotech as its Chief Executive Officer and managing director and has worked as a dedicated advocate for the biotechnology sector since joining AusBiotech over a decade ago. In this role she works closely with public policy impacting the life sciences sector at state and Federal levels, including economic development, tax incentives, patent protection, medical research and its commercialisation.
Michael Lye joined the Department of Health in December 2019 as Deputy Secretary responsible for Ageing and Aged Care.
MTPConnect is a not-for-profit organisation aiming to accelerate the rate of growth of the medical technologies, biotechnologies and pharmaceuticals sector to increase commercialisation, collaboration and establish Australia as an Asia-Pacific hub for MTP companies.
Formed in December 2015 as part of the Federal Government’s Industry Growth Centres Initiative, MTPConnect is an independent and trusted voice, calling for change to support the sector.
Managing Director & Chief Executive Officer
Dr Dan Grant has spent more than 25 years in senior roles in the pharmaceutical, higher education and medical research sectors. Prior to joining MTPConnect, Dr Grant was the inaugural Pro Vice Chancellor for Industry Engagement at La Trobe University where he had oversight of the university's innovation, commercialisation and industry engagement activities. He was also the Senior Director and Head of Pfizer's External Research and Development Innovation group for ANZ/Singapore and their head of open innovation. Dan also sits on the Expert Advisory Panel for the Stem Cell Mission. He has a PhD in Cardiovascular Physiology and an MBA.